Your session is about to expire
← Back to Search
Perioperative Melatonin in Lumbar Laminectomy
N/A
Waitlist Available
Led By Philip Peng, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Summary
Patients undergoing lumbar laminectomy surgery will receive either 5 or 10 mg melatonin or placebo once the evening before surgery and again 90 minutes before surgery. Pain and anxiety will be assessed over the 24 hour period following surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Anxiety
Pain
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Melatonin 5 mgExperimental Treatment1 Intervention
Patients will receive 5 mg melatonin once the evening before surgery and then again at 90 minutes before surgery.
Group II: Melatonin 10 mgExperimental Treatment1 Intervention
Patients will receive 10 mg melatonin once the evening before surgery and then again at 90 minutes before surgery.
Group III: PlaceboPlacebo Group1 Intervention
Patients will receive placebo once the evening before surgery and then again at 90 minutes before surgery.
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,531 Previous Clinical Trials
504,238 Total Patients Enrolled
Philip Peng, MDPrincipal InvestigatorUniversity Health Network, Toronto
1 Previous Clinical Trials
40 Total Patients Enrolled